Repetitive stimulation, also known as repetitive transcranial magnetic stimulation (rTMS), is a non-invasive procedure used to relieve neurological symptoms, such as chronic pain or depression. It is a type of neuromodulation method that works by delivering magnetic pulses through a coil to specific regions in the brain. The patient’s brain is exposed to this pulse for a few minutes at a time. The frequency and intensity of the TMS can be customized depending on the symptoms and the patient’s condition. The goal of rTMS is to improve the function of the affected areas of the brain. The exact mechanism by which rTMS works is not yet known, but researchers believe that the magnetic pulses interact with the neurons in the brain and spark a chain reaction of activity, resulting in the desired changes in the patient’s mental or physical health. Various studies suggest that repetitive stimulation may be beneficial for conditions such as stroke, memory deficits, Parkinson’s disease, and even autistic spectrum disorder. For example, a study conducted by researchers at Harvard Medical School found that the TMS treatment helped improve the motor skills of stroke patients. Other studies have also shown that rTMS may help improve cognitive functions in patients with Alzheimer’s disease. While research is still ongoing, these initial studies suggest that repetitive stimulation may be a promising new method of treating neurological disorders. However, as with any treatment, there are risks associated with repetitive stimulation. For instance, there is the potential for seizures, headaches, or other side effects. Therefore, it is important to work with an experienced physician to ensure that the treatment is tailored appropriately and used safely.
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A Case Report
George Diaz, Memorial Healthcare Systems, United States
Title : Nanoparticles passing the blood brain barrier to treat cancer, infection, and more
Thomas J Webster, Brown University, United States
Title : Transcranial painless neurorehabilitation scalp acupuncture electrical stimulation for neuroregulation of autism spectrum disorder
Zhenhuan Liu, Guangzhou University Chinese Medicine, China
Title : Effects of prenatal androgen exposure on Purkinje cell morphology in the cerebellum of female rats
Kiran Ghotra, Lake Erie College of Osteopathic Medicine, United States